Catalyst
Slingshot members are tracking this event:
XOMA Announces Preclinical Data Evaluating PTH1R in Treatment of Hyperparathyroidism and Humoral Hypercalcemia of Malignancy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| XOMA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 18, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Preclinical Data, Pth1r, Hyperparathyroidism, Humoral Hypercalcemia Of Malignancy
